GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China flag China · Delayed Price · Currency is CNY
11.92
-0.28 (-2.30%)
Nov 18, 2026, 3:00 PM CST

SHA:600771 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
326.92296.75116.67259.97246.4145.15
Cash & Short-Term Investments
472.81296.75116.67259.97246.4145.15
Cash Growth
59.50%154.35%-55.12%5.51%69.76%-63.13%
Accounts Receivable
357.35511.2439.13830.731,0331,460
Other Receivables
13.5411.9710.831.6656.53143.34
Receivables
370.89523.17449.96832.391,0891,603
Inventory
706.91749.98766.95569.53415.04352.9
Other Current Assets
26.0413.6933.8320.3313.1524.07
Total Current Assets
1,5771,5841,3671,6821,7642,125
Property, Plant & Equipment
591.75613.64663.48707.24710.26738.37
Long-Term Investments
12.4415.1716.5725.8932.8953.89
Other Intangible Assets
83.4886.9496.0993.7598.5496.13
Long-Term Deferred Tax Assets
94.0695.3595.9391.6973.6961.29
Long-Term Deferred Charges
2.713.163.794.346.1612.37
Other Long-Term Assets
36.138.9432.6123.2815.3215.37
Total Assets
2,3972,4372,2762,6282,7013,102

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
45.8493.360.2756.41263.87489.08
Accrued Expenses
45.75368.44373.13508.35419.0454.25
Short-Term Debt
9.7819.9556.06165245.86
Current Portion of Long-Term Debt
---189.8662.212
Current Portion of Leases
-8.628.196.331.93-
Current Income Taxes Payable
13.559.852.170.71-1.42
Current Unearned Revenue
107.92125.8850.8369.0238.7820.25
Other Current Liabilities
446.55122.37119.16156.82106.4950.62
Total Current Liabilities
669.31736.46633.71,0441,057873.49
Long-Term Debt
----197.670
Long-Term Leases
19.7625.0733.7939.116.2-
Long-Term Unearned Revenue
24.0519.7615.2715.113.6315.35
Long-Term Deferred Tax Liabilities
2.682.482.413.512.72.81
Other Long-Term Liabilities
---9.27--
Total Liabilities
715.8783.77685.171,1211,277961.65

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
489.49489.49489.49489.49489.49492
Additional Paid-In Capital
859.881,5881,5881,5881,5881,637
Retained Earnings
365.84-441.56-504.61-579.06-669.1417.17
Treasury Stock
-49.98-----51.22
Comprehensive Income & Other
-3.48-3.48-3.29-2.525.554.53
Total Common Equity
1,6621,6331,5701,4961,4142,099
Minority Interest
19.6420.3520.911.749.2541.42
Shareholders' Equity
1,6811,6531,5911,5081,4232,141
Total Liabilities & Equity
2,3972,4372,2762,6282,7013,102

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
29.4641.6961.94291.36432.93327.86
Net Cash (Debt)
443.36255.0654.74-31.39-186.54-182.71
Net Cash Growth
76.85%365.97%----
Net Cash Per Share
0.780.530.10-0.06-0.38-0.37
Filing Date Shares Outstanding
489.49489.49489.49489.49489.49489.49
Total Common Shares Outstanding
489.49489.49489.49489.49489.49489.49
Working Capital
907.35847.13733.71638.67706.651,252
Book Value Per Share
3.393.343.213.062.894.29
Tangible Book Value
1,5781,5461,4741,4021,3162,003
Tangible Book Value Per Share
3.223.163.012.862.694.09
Buildings
-712.62724.01728740.85744.18
Machinery
-168.47165.14161.58162.29162.16
Construction In Progress
-0.42----